InsidersTradesSigma
Follow the 普蕊斯 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 普蕊斯 has logged 7 reports. Market capitalisation: €3.8bn. The latest transaction was disclosed on 26 June 2026 (Sale). Among the most active insiders: 宋卫红. Every trade is free.
7
Insider Decl.
n/a
Thresholds
€195,373
4 ops.
Buy Volume
€444,603
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,846 of 29,063 companies
51.4
score / 100
Value40
Quality62
FCF yld0.9%
Earn yld3.6%
EV/EBITDA21.4x
ROE4.7%
Gross mgn26%
Net mgn13%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 June 2026
Declarations7 total
79,700 sharesA股XSHESZSE:173000009866690530
7 of 7 declarations
关于 普蕊斯
普蕊斯是一家在医疗保健和制药领域运营的公司。该公司在XSHE市场上市。